Report Detail

Pharma & Healthcare Global Glucagon Market Insights, Forecast to 2025

  • RnM3115750
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Glucagon Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Glucagon Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Glucagon Market Size Growth Rate by Product
      • 1.4.2 Inject Glucagon
      • 1.4.3 Nasal Glucagon
    • 1.5 Market by End User
      • 1.5.1 Global Glucagon Market Size Growth Rate by End User
      • 1.5.2 Emergency Kits
      • 1.5.3 General Use
      • 1.5.4 Diagnostic & Motility
      • 1.5.5 Cardiogenic Shock
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Glucagon Market Size
      • 2.1.1 Global Glucagon Revenue 2014-2025
      • 2.1.2 Global Glucagon Sales 2014-2025
    • 2.2 Glucagon Growth Rate by Regions
      • 2.2.1 Global Glucagon Sales by Regions
      • 2.2.2 Global Glucagon Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Glucagon Sales by Manufacturers
      • 3.1.1 Glucagon Sales by Manufacturers
      • 3.1.2 Glucagon Sales Market Share by Manufacturers
      • 3.1.3 Global Glucagon Market Concentration Ratio (CR5 and HHI)
    • 3.2 Glucagon Revenue by Manufacturers
      • 3.2.1 Glucagon Revenue by Manufacturers (2014-2019)
      • 3.2.2 Glucagon Revenue Share by Manufacturers (2014-2019)
    • 3.3 Glucagon Price by Manufacturers
    • 3.4 Glucagon Manufacturing Base Distribution, Product Types
      • 3.4.1 Glucagon Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Glucagon Product Type
      • 3.4.3 Date of International Manufacturers Enter into Glucagon Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Glucagon Sales by Product
    • 4.2 Global Glucagon Revenue by Product
    • 4.3 Glucagon Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Glucagon Breakdown Data by End User

    6 North America

    • 6.1 North America Glucagon by Countries
      • 6.1.1 North America Glucagon Sales by Countries
      • 6.1.2 North America Glucagon Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Glucagon by Product
    • 6.3 North America Glucagon by End User

    7 Europe

    • 7.1 Europe Glucagon by Countries
      • 7.1.1 Europe Glucagon Sales by Countries
      • 7.1.2 Europe Glucagon Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Glucagon by Product
    • 7.3 Europe Glucagon by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Glucagon by Countries
      • 8.1.1 Asia Pacific Glucagon Sales by Countries
      • 8.1.2 Asia Pacific Glucagon Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Glucagon by Product
    • 8.3 Asia Pacific Glucagon by End User

    9 Central & South America

    • 9.1 Central & South America Glucagon by Countries
      • 9.1.1 Central & South America Glucagon Sales by Countries
      • 9.1.2 Central & South America Glucagon Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Glucagon by Product
    • 9.3 Central & South America Glucagon by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Glucagon by Countries
      • 10.1.1 Middle East and Africa Glucagon Sales by Countries
      • 10.1.2 Middle East and Africa Glucagon Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Glucagon by Product
    • 10.3 Middle East and Africa Glucagon by End User

    11 Company Profiles

    • 11.1 Novo Nordisk
      • 11.1.1 Novo Nordisk Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novo Nordisk Glucagon Products Offered
      • 11.1.5 Novo Nordisk Recent Development
    • 11.2 Eli Lilly
      • 11.2.1 Eli Lilly Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Eli Lilly Glucagon Products Offered
      • 11.2.5 Eli Lilly Recent Development
    • 11.3 Fresenius Kabi
      • 11.3.1 Fresenius Kabi Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Fresenius Kabi Glucagon Products Offered
      • 11.3.5 Fresenius Kabi Recent Development
    • 11.4 Torrent Labs
      • 11.4.1 Torrent Labs Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Torrent Labs Glucagon Products Offered
      • 11.4.5 Torrent Labs Recent Development
    • 11.5 Taj Pharmaceuticals
      • 11.5.1 Taj Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Taj Pharmaceuticals Glucagon Products Offered
      • 11.5.5 Taj Pharmaceuticals Recent Development
    • 11.6 Xeris Pharmaceuticals
      • 11.6.1 Xeris Pharmaceuticals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Xeris Pharmaceuticals Glucagon Products Offered
      • 11.6.5 Xeris Pharmaceuticals Recent Development

    12 Future Forecast

    • 12.1 Glucagon Market Forecast by Regions
      • 12.1.1 Global Glucagon Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Glucagon Revenue Forecast by Regions 2019-2025
    • 12.2 Glucagon Market Forecast by Product
      • 12.2.1 Global Glucagon Sales Forecast by Product 2019-2025
      • 12.2.2 Global Glucagon Revenue Forecast by Product 2019-2025
    • 12.3 Glucagon Market Forecast by End User
    • 12.4 North America Glucagon Forecast
    • 12.5 Europe Glucagon Forecast
    • 12.6 Asia Pacific Glucagon Forecast
    • 12.7 Central & South America Glucagon Forecast
    • 12.8 Middle East and Africa Glucagon Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Glucagon Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
      The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.
      Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and other field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.
      North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
      Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
      The global Glucagon market is valued at 430 million US$ in 2018 and will reach 700 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glucagon market based on company, product type, end user and key regions.

      This report studies the global market size of Glucagon in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glucagon in these regions.
      This research report categorizes the global Glucagon market by top players/brands, region, type and end user. This report also studies the global Glucagon market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Novo Nordisk
      Eli Lilly
      Fresenius Kabi
      Torrent Labs
      Taj Pharmaceuticals
      Xeris Pharmaceuticals

      Market size by Product
      Inject Glucagon
      Nasal Glucagon
      Market size by End User
      Emergency Kits
      General Use
      Diagnostic & Motility
      Cardiogenic Shock
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Glucagon market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Glucagon market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Glucagon companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Glucagon submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Glucagon are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glucagon market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Glucagon . Industry analysis & Market Report on Glucagon is a syndicated market report, published as Global Glucagon Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Glucagon market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,618.85
      3,928.28
      5,237.70
      3,588.78
      5,383.17
      7,177.56
      472,446.00
      708,669.00
      944,892.00
      258,622.26
      387,933.39
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report